European Financial Statements From 2010 to 2024
| EBACDelisted Stock | USD 11.19 0.10 0.90% |
Check European Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among European main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . European financial statements analysis is a perfect complement when working with European Biotech Valuation or Volatility modules.
European |
European Biotech Acquisition Company Number Of Shares Shorted Analysis
European Biotech's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current European Biotech Number Of Shares Shorted | 258.83 K |
Most of European Biotech's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, European Biotech Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, European Biotech Acquisition has 258.83 K of outstending shares currently sold short by investors. This is 95.51% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The number of shares shorted for all United States stocks is 94.5% higher than that of the company.
European Biotech Acq Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining European Biotech's current stock value. Our valuation model uses many indicators to compare European Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across European Biotech competition to find correlations between indicators driving European Biotech's intrinsic value. More Info.European Biotech Acquisition is rated as one of the top companies in current valuation category among related companies. It is one of the top stocks in shares outstanding category among related companies creating about 0.08 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for European Biotech Acquisition is roughly 12.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value European Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for European Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the European Biotech's earnings, one of the primary drivers of an investment's value.About European Biotech Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include European Biotech income statement, its balance sheet, and the statement of cash flows. European Biotech investors use historical funamental indicators, such as European Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although European Biotech investors may use each financial statement separately, they are all related. The changes in European Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on European Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on European Biotech Financial Statements. Understanding these patterns can help to make the right decision on long term investment in European Biotech. Please read more on our technical analysis and fundamental analysis pages.
European Biotech Acquisition Corp. does not have significant operations. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands. European Biotech is traded on NASDAQ Exchange in the United States.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards European Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, European Biotech's short interest history, or implied volatility extrapolated from European Biotech options trading.
Pair Trading with European Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if European Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in European Biotech will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to European Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace European Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back European Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling European Biotech Acquisition to buy it.
The correlation of European Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as European Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if European Biotech Acq moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for European Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the European Biotech Acq information on this page should be used as a complementary analysis to other European Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in European Stock
If you are still planning to invest in European Biotech Acq check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the European Biotech's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |